戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              NSE > 33 ng/ml has a high false-positive rate in patient
2                                              NSE > 33 ng/ml levels measured 1-3 days after cardiac ar
3                                              NSE and tau are better associated with NCD and less infl
4                                              NSE and tau protein at the 6-hour time point were both s
5                                              NSE can pinpoint the nanoscale dynamics changes in a hig
6                                              NSE directly probes coherent (i.e., pair correlated) sca
7                                              NSE levels were assessed in blood samples obtained 24, 4
8                                              NSE levels were deregulated in leukemias and were influe
9                                              NSE reveals that, in the cadherin-catenin complex, the m
10                                              NSE was a robust predictor of neurological outcome in a
11                                              NSE, S100beta, or BIS alone predicted neurological outco
12                                              NSE-apoE mice and similar models may facilitate the prec
13                                              NSE-Rb db/db mice were infected with T. cruzi to determi
14  = 0.983; at t + 7: R = 0.997, RMSE = 0.249, NSE = 0.994; at t + 14: R = 0.996, RMSE = 0.304, NSE = 0
15 d NO-mediated compensatory responses in 2K1C NSE-AT(1a) peripheral arteries during this later phase,
16 = 0.994; at t + 14: R = 0.996, RMSE = 0.304, NSE = 0.991).
17 ing level at t + 3: R = 0.992, RMSE = 0.426, NSE = 0.983; at t + 7: R = 0.997, RMSE = 0.249, NSE = 0.
18 are always slender and elongate, the PGP 9.5/NSE population comprise two morphological types--one sle
19 lar in overall shape to the pyriform PGP 9.5/NSE population, gustducin never colocalizes with PGP 9.5
20 W-M04, is achieved over Drammen (r = 0.9765, NSE = 0.9510, KGE = 0.8641, PI = 0.3211, and RMSE = 0.22
21             AR-M5P (R(2) = 0.954, R = 0.977, NSE = 0.954, MAE = 0.042, MSE = 0.003, and PBias = 1.466
22 rge, with evaluation criteria of CC = 0.983, NSE = 0.962, RMSE = 0.178, and MAE = 0.071.
23 r 36 degrees C does not significantly affect NSE levels.
24 get temperature did not significantly affect NSE values.
25 menting these synergistic properties affords NSE-based planar PSCs that deliver a remarkable power co
26                                   The AIMNet-NSE model allows to fully bypass QM calculations and der
27    Built upon the AIMNet2 framework, AIMNet2-NSE is trained on an extensive dataset comprising 20 mil
28                             Overall, AIMNet2-NSE represents a significant advancement in machine lear
29                      Here we present AIMNet2-NSE (neural spin-charge equilibration), a neural network
30                The neuronal expression of an NSE-Fig4(Cys486Ser) transgene in vivo prevented the neon
31 2 hours after CPR (FPR 10; 95% CI, 6-16) and NSE levels were not.
32  among patients and HC separately, IL-18 and NSE concentrations were positively correlated (p < 0.001
33   Double-label studies show that PGP 9.5 and NSE always colocalize.
34 cted C-33 LNCaP cells, ERK was activated and NSE level was elevated, and cells obtained the NE-like p
35 cted C-33 LNCaP cells, ERK was activated and NSE was elevated.
36  presence of PD98059, the ERK activation and NSE elevation were abolished, following a dose-response
37 , but also for immobilization of the CEA and NSE aptamers.
38 on in serum IL-6, IL-1beta, epinephrine, and NSE levels from baseline to 48 h post-injury (p = 0.001)
39 mice compared with those in infected FVB and NSE-Rb db/db mice.
40 the resulting inflammation in Hand2(+/-) and NSE-noggin mice was compared with that of wild-type litt
41 e robust expression of the NE genes HRH1 and NSE/ENO2 in KSHV-infected KS tissue samples and KS visce
42 mflow simulation testing gave RMSE, MAE, and NSE of 1.65, 1.21 MCM/month, and 0.80, respectively.
43 ion of botanicals, for instance NeemAzal and NSE deterred oviposition of S. litura.
44 ntin, and negative for A2B5, CNPase, NF, and NSE.
45 oncentrations of S100B, GFAP, BDNF, NFL, and NSE were assessed in 48 collegiate football players (32
46 the detection of the NSE derived peptide and NSE.
47 s approach is the multiplexing of ProGRP and NSE with the additional ability to perform fingerprintin
48 ighest concentrations in week 1 of S100B and NSE were associated with poor outcome, as were highest c
49 te small-angle neutron scattering (SANS) and NSE scattering properties.
50 64 dysregulated TF-miRNA-gene FFLs in SE and NSE, respectively.
51 d the formation mechanism of the CE, SSE and NSE is largely debated today, yet the upwelling and biol
52 UN, KLF4, PLXDC2, RND3, SPI1, and TIMP3) and NSE-specific dysregulated miRNAs (miR-367-3p, miR-519d-3
53 n support substantial immobilisation of anti-NSE agent.
54                                     The anti-NSE immobilized BP-TFG biosensor has been implemented to
55 uron-specific enolase promoter-driven apoE3 (NSE-apoE3) or apoE4 (NSE-apoE4) transgenic mice.
56  promoter-driven apoE3 (NSE-apoE3) or apoE4 (NSE-apoE4) transgenic mice.
57 N-LEPR-B and neuron-specific enolase-LEPR B (NSE-LEPR-B).
58 ry roles involving the TL difference between NSE and SE, and provided a better molecular understandin
59 ferent telomere length (TL) features between NSE (n = 48) and SE (n = 55).
60                      Emerging CSF biomarkers NSE, VLP-1, HFABP, and YKL-40 were moderately associated
61  blot analysis was performed on bitransgenic NSE-tTA, TetOp-DeltaFosB, and single-transgenic NSE-tTA
62 e hypothesize that increased levels of blood NSE may characterize LHON carriers as a biomarker of ong
63 s of db/db mice that are hemizygous for both NSE-LEPR-B and SYN-LEPR-B transgenes (Nse+Syn db/db).
64 tals the enzyme forms the asymmetric complex NSE x Mg2 x SO4/NSE x Mg x Cl, where "/" separates the d
65  with NSE-apoE3 mice and wild-type controls, NSE-apoE4 mice showed impairments in learning a water ma
66 flexes, and motor scores 72 hours after CPR; NSE levels at admission, 12 hours after reaching target
67  or using a genetic approach (Nestin-CreERT2/NSE-DTA mice) impeded the forgetting of old memories.
68 th Alzheimer's disease, whereas those of CSF NSE, VLP-1, HFABP, and YKL-40 were moderate (average rat
69 -preferring mice that overexpress DeltaFosB (NSE-tTA x TetOp-DeltaFosB) exhibit less avoidance of the
70 molecule diffusion to the simulation-derived NSE and potential problems in their estimation are exami
71 TFG biosensor has been implemented to detect NSE biomarkers demonstrating ultrahigh sensitivity with
72 r was demonstrated successful in determining NSE in clinical serum samples.
73 a marker for the overall nerve distribution, NSE antibodies revealed abundant smooth and varicose ner
74 etic or biochemical tumor marker (MYCN, DNA, NSE, or ferritin), or by both unamplified MYCN and aneup
75           Higher diversity in the CSF during NSE was associated with greater CNS inflammation.
76 ron scattering (SANS) and neutron spin echo (NSE) spectroscopy were used to measure the tertiary stru
77 ensive approach-combining neutron spin-echo (NSE) spectroscopy, solid-state deuterium NMR ((2)H NMR)
78 , may exert beneficial non-specific effects (NSE) in reducing infant mortality.
79 gside the highest Nash-Sutcliffe efficiency (NSE) of 0.8048 and Pearson correlation coefficient (PCC)
80 ters based on the Nash-Sutcliffe Efficiency (NSE) to evaluate the TLBO's predictive skill using bench
81 : see text]), and Nash-Sutcliffe efficiency (NSE) values corresponding [Formula: see text] and [Formu
82 are error (RMSE), Nash-Sutcliffe efficiency (NSE), Kling-Gupta efficiency (KGE) and Mean bias error (
83 he models based on interval-PLS efficiently (NSE >= 0.90) predicted storage time with low errors (RSR
84 ti-zwitterionic small-molecule electrolytes (NSEs) are introduced, which act not only as charge-extra
85 30.4 %) carriers with significantly elevated NSE levels (mean = 75.8 +/- 42.3 mug/L), 9/14 (64.3%) we
86 levation (STE) and non-ST-segment elevation (NSE) groups and by the presence or absence of abnormal R
87 f 2.8 kb of the rat neuron-specific enolase (NSE) 5' flanking region fused to a cDNA encoding the ful
88     Serum levels of neuron-specific enolase (NSE) and neuron-enriched S100 beta (S100beta) were measu
89 ght chain (NfL) and neuron-specific enolase (NSE) are associated with poor neurological outcome after
90 ular recognition of neuron specific enolase (NSE) biomarker.
91  diagnosis of human neuron-specific enolase (NSE) cancer biomarkers.
92       Moreover, the neuron-specific enolase (NSE) immunohistochemistry results revealed the protectiv
93 c antigen (CEA) and neuron-specific enolase (NSE) in a clinical sample with high sensitivity and spec
94                     Neuron-specific enolase (NSE) is a biomarker for neuronal stress.
95                     Neuron-specific enolase (NSE) is a widely-used biomarker for prognostication of n
96 eptide (ProGRP) and neuron specific enolase (NSE) is presented, which involves coextraction by immuno
97  were mortality and neuron-specific enolase (NSE) levels on days 1 and 3.
98               Serum neuron specific enolase (NSE) measurements, brain imaging findings, somatosensory
99 ining for MCP-1 and neuron specific enolase (NSE) or glial fibrillary acidic protein (GFAP) showed th
100               Human neuron-specific enolase (NSE) or isozyme gamma has been expressed with a C-termin
101  that antibodies to neuron-specific enolase (NSE) preferentially label a subpopulation of photorecept
102 s incorporating the neuron specific enolase (NSE) promoter and either a rat GAP-43 cDNA or the corres
103 c, incorporated the neuron-specific enolase (NSE) promoter and the internal ribosome entry site (IRES
104 nder control of the neuron-specific enolase (NSE) promoter develops a FOP-like phenotype.
105 rol of 1.8-kilobase neuron-specific enolase (NSE) promoter for this purpose.
106 nic mice using the neuron- specific enolase (NSE) promoter or a modified glial fibrillary acidic prot
107  the control of the neuron-specific enolase (NSE) promoter show both markedly increased bone formatio
108 n, we have used the neuron-specific enolase (NSE) promoter to express human apoE3 or apoE4 at similar
109 nder control of the neuron specific enolase (NSE) promoter.
110 nder control of the neuron-specific enolase (NSE) promoter.
111 chemical sensor for neuron specific enolase (NSE) was developed by electrochemical polymerizing ionic
112 ogranin A (CgA) and neuron-specific enolase (NSE) were assessed monthly if elevated at baseline.
113 llometry, and serum neuron-specific enolase (NSE) were retrieved.
114  increased level of neuron-specific enolase (NSE), a classical marker of neuronal cells.
115 ed for detection of neuron-specific enolase (NSE), a traumatic brain injury (TBI) protein biomarker,
116  biomarkers [S100B, Neuron-Specific Enolase (NSE), and epinephrine].
117 neuromarkers S100B, neuron-specific enolase (NSE), and glial fibrillary acidic protein (GFAP), in add
118 ologic examination, neuron-specific enolase (NSE), and median nerve somatosensory-evoked potentials (
119             S-100b, neuron specific enolase (NSE), and tau protein were assayed as MBIs preoperativel
120 odified epitopes of neuron specific enolase (NSE), as-synthesized gold nanoparticles (AuNPs), and fun
121 these cells contain neuron-specific enolase (NSE), tyrosine hydroxylase (TH) and 5-hydroxytryptamine
122  rabbit antisera to neuron-specific enolase (NSE), tyrosine hydroxylase (TH), neuropeptide Y (NPY), v
123          Serotonin, neuron-specific enolase (NSE), ubiquitin carboxyl terminal hydrolase (PGP 9.5), a
124 r apoE4 in neurons [neuron-specific enolase (NSE)-apoE] or astrocytes [glial fibrillary acidic protei
125 o-localization with neuron-specific enolase (NSE)-IR, but is especially prominent in cell bodies of a
126 ofilament (NF), and neuron specific enolase (NSE).
127 or the detection of neuron-specific enolase (NSE).
128 ne ionic liquid and neuron specific enolase (NSE).
129 accuracy than serum neuron-specific enolase (NSE; the area under the receiver operating characteristi
130 receptor H1 [HRH1], neuron-specific enolase [NSE] [ENO2], neuronal protein gene product 9.5 [PGP9.5],
131 protein [GFAP], and neuron-specific enolase [NSE]), and information about intracranial pressure lower
132 earing a transgene (neuron-specific enolase [NSE]-Rb) expressing the B isoform of LEPR, the isoform c
133 ndings of nonspecific small bowel enteritis (NSE) on capsule endoscopy (CE) poses a clinical challeng
134 sion in children with nonsyndromic epilepsy (NSE) over the course of >/=10 years from initial diagnos
135 osal biopsies of normal squamous epithelium (NSE), BE and EAC obtained from a patient who progressed
136  sex ratio, and neritic survival equivalent [NSE]) computed from simulations better predicted each ot
137  this setting of shared physiologic erasure, NSEs harbor a malignancy-associated hypermethylation cor
138 efined as neurosymptomatic HIV-1 CSF escape (NSE).
139 phosphatase (TRAP) and nonspecific esterase (NSE) activity, which are selective markers for the osteo
140  exploration of a Natural Sources Exclusion (NSE) provision within the TMDL.
141 key nonsense-mediated RNA decay switch exon (NSE) in ATM is repressed by U2AF, PUF60 and hnRNPA1.
142   Surprisingly, most of the cells expressing NSE::LacZ outside the olfactory bulb were astrocytes.
143 apoE4 and, to a significantly lesser extent, NSE-apoE3 mice; however, no fragments were detected in G
144 ormulation NeemAzal and a neem seed extract (NSE) were evaluated in field spraying trials alongside c
145 EA (R(2) = 0.989) and 0.05-500 ng mL(-1) for NSE (R(2) = 0.944), respectively.
146 was 2 pg mL(-1) for CEA and 10 pg mL(-1) for NSE.
147 des (12 out of 30 for SE and 8 out of 32 for NSE) in the top ranked FFLs could predict subtype-classi
148 cteristic curve was 0.91 for tau vs 0.86 for NSE at 72 hours, p = 0.00024).
149 nts of 2.3 x 10(-10) M and 3 x 10(-11) M for NSE recognition using the corresponding epitope imprints
150 nstructed platform was successfully used for NSE determination in human serum samples.
151                                 Furthermore, NSE levels were nearly three times greater in asymptomat
152  pM (=700 pg/mL), for total ProGRP and gamma-NSE, respectively.
153 munometric assays for total ProGRP and gamma-NSE, were seen in the analyses of patient serum samples.
154 usly identified proteins (CRMP1, CRMP2, GDA, NSE, LDHA, LDHB, STIP1, and YBOX) that are highly expres
155                              At 48 and 72 h, NSE predicted neurological outcome with areas under the
156               Of 613 cohort members, 347 had NSEs, of whom 294 (85%) were followed >/=10 years (maxim
157                                         High NSE cutoff values with false positive rates </=5% and ti
158 r-derived features, performed best with high NSE (0.86), KGE (0.80), and R (0.93) values during calib
159 C, MAE of 1.9867, RAE of 29.5440, and higher NSE of 0.8720 and R2 of 0.8720.
160 sitive participants had significantly higher NSE (3713 vs. 2200 pg/ml, p < 0.001) and IL-18 levels th
161 ) values during calibration, and the highest NSE (0.83), KGE (0.88), R (0.91), and lowest RMSE (892)
162 y exacerbation of renovascular hypertension, NSE-AT(1a) and nontransgenic (NT) mice underwent 2-kidne
163                     To test this hypothesis, NSE-tTA x TetOp-DeltaFosB mice with normal or overexpres
164 r high-flow events, as evidenced by improved NSE (from 0.83 to 0.97) and reduced RMSE (from 892 to 44
165                                           In NSE-apoE mice, the pattern of apoE fragmentation resembl
166 dia accompanied this early increase in BP in NSE-AT(1a) mice, as did a substantial cardiovascular reg
167 rtan caused significant falls in basal BP in NSE-AT1a mice but had no effect in nontransgenic control
168 ceptors to the maintenance of baseline BP in NSE-AT1a mice, particularly effective baroreflex bufferi
169 -old NSE-apoE4 mice but barely detectable in NSE-apoE3 mice.
170  We found that TL elongation was dominant in NSE, whereas TL shortening prevailed in SE.
171 ively correlated with telomere elongation in NSE than SE: three telomerase activity-related genes (TE
172  factors might induce telomere elongation in NSE.
173  them, SOX2 and MYC were highly expressed in NSE versus SE, while POU5F1 and KLF4 had the opposite pa
174               LEPR-B transgene expression in NSE-Rb db3J/db3J mice partially corrected the increased
175 -apoE4 mice and, to a much lesser extent, in NSE-apoE3 mice but not in GFAP-apoE3 or GFAP-apoE4 mice.
176 ignificantly increased apoE fragmentation in NSE-apoE4 but not NSE-apoE3 mice.
177         The decrease in cerebellar growth in NSE(Cre/+)/CII(F/F) mice is due to reduced proliferation
178 nd2(+/-) mice and significantly increased in NSE-noggin animals.
179 vely correlated with telomere lengthening in NSE.
180  stabilized at significantly lower levels in NSE-AT(1a) mice despite marked elevations in Ang II leve
181 mplexes assessed were significantly lower in NSE-apoE4 neurons compared with NSE-apoE3 neurons.
182 so accumulated in an age-dependent manner in NSE-apoE4 mice and, to a much lesser extent, in NSE-apoE
183 monal profile was only partially restored in NSE-HPrP/mPrP(0/0) mice and was similar to that of mPrP(
184     The NREM and SWA deficit was restored in NSE-HPrP/mPrP(0/0) mice but not in GFAP-HPrP/mPrP(0/0).
185 unctional overexpression of the transgene in NSE-AT1a mice.
186    The control vector, pTR-UF4, incorporated NSE promoter-driven GFP expression only.
187 d db/db mice compared with those in infected NSE-Rb db/db and FVB wild-type mice.
188  SSPE patients and our work with MV-infected NSE-CD46(+) mice, which express the measles receptor CD4
189  comprised markers of cellular brain injury (NSE, BDNF, GFAP, S100beta, MCP1, VILIP-1, neurogranin);
190  the full complement of short LEPR isoforms (NSE-Rb db/db mice) were similar to those of NSE-Rb db3J/
191 vioral analyses, we demonstrate that NRG1-IV/NSE-tTA mice exhibit abnormal behaviors relevant to schi
192  developed a transgenic mouse model (NRG1-IV/NSE-tTA) in which human NRG1-IV is selectively overexpre
193 (MD-8), the values RMSE (m(3)/s), R(2), MAE, NSE, KGE and MBE are 4.57, 0.98, 2.56, 0.98, 0.94 and 0.
194 ike morphology and expression of NE markers (NSE).
195                                       Median NSE values were 18 ng/ml versus 35 ng/ml, 15 ng/ml versu
196 eceptor was constructed and transgenic mice (NSE-AT1a) were generated.
197         In genetically modified db/db mice, (NSE-Rb db/db mice), central leptin signaling is reconsti
198 petition of adjacent pseudoexons to modulate NSE levels.
199  and multinucleated cells and TRAP-negative, NSE-positive mononuclear precursors were identified.
200 l activation (NT-proCNP), neurodegeneration (NSE, tau), neuroaxonal damage (NfL, NfH, UCHL-1) and gli
201 ic and central expression of PrP in neurons (NSE-HPrP/mPrP(0/0)) or in glia cells (GFAP-HPrP/mPrP(0/0
202 rs reflecting neurodegeneration (T-tau, NFL, NSE, VLP-1, and HFABP), APP metabolism (Abeta42, Abeta40
203 clinically as seminoma (SE) and nonseminoma (NSE), the latter including the pluripotent embryonal car
204 ansgenic mice that have greater than normal (NSE-noggin mice, which overexpress noggin under the cont
205 ased apoE fragmentation in NSE-apoE4 but not NSE-apoE3 mice.
206  mononuclear/giant cells, and the occasional NSE-positive precursor, expressed an intense signal for
207 s signal sensitivity up to 0.12 ng mL(-1) of NSE with excellent signal reproducibility and electrode
208                        CD occurred in 19% of NSE patients on follow up.
209                        The majority (49%) of NSE patients do not develop significant small bowel dise
210 3% (4/28), 16.0% (8/50) and 12.2% (12/98) of NSE, BE, low-grade dysplasia, HGD and EAC tissues, respe
211                            The appearance of NSE immunoreactivity in the different classes of retinal
212 in an age-dependent manner, in the brains of NSE-apoE4 and, to a significantly lesser extent, NSE-apo
213 nt production of beta-s-APP in the brains of NSE-APP mice and enzyme-linked immunosorbent assay analy
214  expression was reduced in the cerebellum of NSE(Cre/+)/CII(F/F) mice, thereby leading to decreased A
215                            Colocalization of NSE with SV2 indicated that cone cells began to make syn
216 hey also demonstrate that the combination of NSE with MD is potentially useful for determining the fo
217                             The detection of NSE, relied on its obstruction in analytical signal obse
218  the NE-like morphology and the elevation of NSE in C-33 LNCaP cells.
219                         Axonal extensions of NSE-labeled cone cells were shown to interact with those
220                   Patients with a finding of NSE were identified from a database.
221             To define the natural history of NSE in an Irish cohort.
222                                    Levels of NSE and S100beta were higher in patients with poor outco
223 suggests that the decreased fat phenotype of NSE-DeltaFosB mice is independent of the changes in the
224  great extent and allowed the recognition of NSE in human serum in a concentration range of 25-4000 p
225                           The recognition of NSE was achieved by the same imprints in a linear range
226          This study investigated the role of NSE as a prognostic marker of outcome after out-of-hospi
227  well as the alpha- and the gamma-subunit of NSE isoenzymes.
228 d by ELISA specific for the gamma subunit of NSE.
229 (NSE-Rb db/db mice) were similar to those of NSE-Rb db3J/db3J mice, suggesting that the short LEPR is
230                          The body weights of NSE-Rb transgenic mice that possessed the full complemen
231 e hippocampus were prominent in 21-month-old NSE-apoE4 mice but barely detectable in NSE-apoE3 mice.
232  gustducin never colocalizes with PGP 9.5 or NSE.
233                Patients with an early CgA or NSE response had a longer PFS compared with patients wit
234 olume associations were observed for GFAP or NSE, and no treatment group differences were detected.
235 erapeutic hypothermia, use of motor score or NSE, as recommended in current guidelines, could possibl
236 = 14 (16%), NSAIDs = 12 (14%) and persistent NSE = 2 (2%).
237 (IBS), NSAIDs enteritis (NSAIDs), persistent NSE and no significant disease (NAD).
238 er between and individually quantify ProGRP, NSE, and their isoform and isoenzyme variants, respectiv
239 rol of the neuron-specific enolase promoter (NSE-PDGF-A) resulted in a striking hyperplasia of retina
240 control of neuron-specific enolase promoter (NSE::LacZ) from the SVZ of adult mice into the striatum
241 f angiotensin II (Ang II) type 1a receptors (NSE-AT(1a)) to unmask the role of the brain renin-angiot
242                               After removing NSE templates, a molecularly imprinted sensor was succes
243 concentrations) and brain biomarkers (S100B, NSE, NFL, tau, UCH-L1, and GFAP) were consistently found
244 nd an increasing profile over time in S100B, NSE, and GFAP.
245           Biomarkers of brain injury (S100B, NSE, NFL, tau, UCH-L1, and GFAP) were also top clinical
246                                    Mean (SD) NSE levels on day 1 after cardiac arrest were significan
247 in subtypes, seminoma (SE) and non-seminoma (NSE), but their molecular distinctions remain largely un
248 mors (TGCT): seminoma (SE) and non-seminoma (NSE).
249                                 High, serial NSE values are strong predictors of poor outcome after O
250  expressed as seropositivity/seronegativity, NSE and IL-18 were measured with immunoassays.
251                                        Serum NSE concentrations in carriers (27.17 +/- 39.82 mug/L) w
252                                        Serum NSE levels are higher in LHON carriers compared with aff
253                                        Serum NSE levels were determined by ELISA specific for the gam
254 le carriers had significantly elevated serum NSE levels.
255  reactivity and 4) continuity, 5) peak serum NSE within 48 hours less than or equal to 41 ug/L, and 6
256    It may be significantly better than serum NSE, which is recommended in guidelines and currently us
257 Op-DeltaFosB founder lines but not in single NSE-tTA transgenic controls.
258 forms the asymmetric complex NSE x Mg2 x SO4/NSE x Mg x Cl, where "/" separates the dimer subunits.
259 P-TFII knockout mice using a tissue-specific NSE-Cre recombinase.
260        Using neutron spin-echo spectroscopy (NSE), normal mode analysis, and a statistical-mechanical
261 omplex using neutron spin echo spectroscopy (NSE), selective deuteration, and theoretical physics ana
262        Using Neutron Spin Echo Spectroscopy (NSE), we have investigated the undulation dynamics of Sy
263        Using neutron spin echo spectroscopy (NSE), we show salt-concentration-dependent excitation of
264 plication of neutron spin-echo spectroscopy (NSE).
265 g/mL, which is 4 orders magnitude lower than NSE cut-off value of small cell lung cancer.
266                                 We show that NSE spectroscopy can determine the domain mobility tenso
267                            Results show that NSE-AT(1a) mice developed hypertension much more rapidly
268                                          The NSE activation was haplotype-specific and was most promo
269                                          The NSE index is calculated 0.99 and 0.94 for the Wilson and
270                                          The NSE results provide insights into the nature of protein
271                                          The NSE-immunoreactive photoreceptors were identified as con
272                                          The NSE-Rb transgene was expressed in the brain, with low le
273                                  Because the NSE promoter drives expression primarily in neurons, thi
274  similar to that previously reported for the NSE-LEPR-B transgene.
275       The synthetic peptide derived from the NSE was synthesized along with its cysteine and histidin
276 most promoted by cytosine at rs609621 in the NSE 3' splice-site (3'ss), which is predominant in high
277 k of mortality/MI (hazard ratio 0.93) in the NSE group at 180 days.
278  ratio 0.79 in the STE group and 0.81 in the NSE group) and with risk of mortality/MI (hazard ratio 0
279                                       In the NSE group, 8152 of 19 304 (42%) had abnormal RF.
280 spite this partial rescue, later in life the NSE-Fig4(Cys486Ser) transgenic mice display significant
281 LFS was successfully employed to measure the NSE level in clinical blood plasma samples taken from de
282  confirm that a significant component of the NSE arises from internal dynamics.
283 ents and theoretical physics analyses of the NSE data reveal that the dynamics of full-length alpha-c
284  cavities were used for the detection of the NSE derived peptide and NSE.
285              The late onset phenotype of the NSE-Fig4(Cys486Ser) transgenic mice demonstrates that th
286 dates as the mediators of the effects of the NSE-Rb transgene on energy homeostasis, ingestive behavi
287 te the internal motion's contribution to the NSE signal, with the largest being classic hinge bending
288                                    Among the NSEs, Nse5 and Nse6 form a stable subcomplex (Nse5-6) th
289 id cyclases in that it does not contain the "NSE/DTE" motif on helix H that specifically chelates Mg(
290 ith the surfactant in the trans form through NSE measurements of the Q-dependent effective diffusion
291 wed high selectivity and sensitivity towards NSE, produced a linear response in the concentration ran
292 -tTA, TetOp-DeltaFosB, and single-transgenic NSE-tTA control mice to determine the pattern of DeltaFo
293  interfacial and bulk trap passivation using NSE modifiers is a promising strategy to overcome outsta
294 king blood vessel endothelial cells, whereas NSE-IR apparently marks the layer of smooth muscle cells
295 ignificantly elevated S-100b levels, whereas NSE and tau were not significantly influenced.
296 F-IR is more prominent in the nucleus, while NSE-IR is more prominent in the cytoplasm and neurites.
297 rus 1 IgG status showed no associations with NSE or IL-18 which may suggest TOXO specificity.
298                                Compared with NSE-apoE3 mice and wild-type controls, NSE-apoE4 mice sh
299 tly lower in NSE-apoE4 neurons compared with NSE-apoE3 neurons.
300 13 bird exclusion structure, consistent with NSE.
301 occurs in over one-half of young people with NSE and generally persists.

 
Page Top